Zura Bio Ltd. Files Definitive Proxy Statement

Ticker: ZURA · Form: DEF 14A · Filed: Sep 13, 2024 · CIK: 1855644

Zura Bio Ltd DEF 14A Filing Summary
FieldDetail
CompanyZura Bio Ltd (ZURA)
Form TypeDEF 14A
Filed DateSep 13, 2024
Risk Levellow
Pages16
Reading Time20 min
Key Dollar Amounts$0.0001, $18,750
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, governance, regulatory-filing

TL;DR

Zura Bio filed its proxy statement - shareholders vote soon on company matters.

AI Summary

Zura Bio Ltd. filed a definitive proxy statement (DEF 14A) on September 13, 2024, for its annual meeting of stockholders. The filing concerns the company's corporate governance and matters to be voted on by shareholders. Zura Bio Ltd. is incorporated in E9 and has its fiscal year end on December 31.

Why It Matters

This filing provides shareholders with crucial information regarding the company's leadership, voting matters, and corporate governance, enabling informed participation in shareholder decisions.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) that does not contain new financial performance data or significant strategic changes.

Key Numbers

  • 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)

Key Players & Entities

  • Zura Bio Ltd (company) — Registrant
  • 0001104659-24-099807 (filing_id) — Accession Number
  • 20240913 (date) — Filing Date
  • 20241023 (date) — Period of Report
  • JATT Acquisition Corp (company) — Former Company Name

FAQ

What type of filing is this?

This is a Definitive Proxy Statement (DEF 14A).

Who is the registrant?

The registrant is Zura Bio Limited.

When was this filing made?

The filing was made on September 13, 2024.

What is the period of report for this filing?

The period of report is October 23, 2024.

What was Zura Bio Ltd. formerly known as?

Zura Bio Ltd. was formerly known as JATT Acquisition Corp.

Filing Stats: 4,921 words · 20 min read · ~16 pages · Grade level 11.9 · Accepted 2024-09-13 16:22:01

Key Financial Figures

  • $0.0001 — ny's Class A ordinary shares, par value $0.0001 per share. Why did I receive a notice
  • $18,750 — ce Advisors, LLC a fee of approximately $18,750 and will reimburse Alliance Advisors, L

Filing Documents

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 32 HOUSEHOLDING OF PROXY MATERIALS 40 SHAREHOLDER PROPOSALS FOR THE 2025 ANNUAL GENERAL MEETING OF SHAREHOLDERS 40 OTHER MATTERS 41 i TABLE OF CONTENTS ZURA BIO LIMITED 1489 W. Warm Springs Rd. #110 Henderson, Nevada 89014 (702) 825-9872 PROXY STATEMENT FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON WEDNESDAY, OCTOBER 23, 2024 AT 12:00 P.M. EASTERN TIME QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING We are providing you with these proxy materials because the Board of Directors of Zura Bio Limited, or the "Board", is soliciting your proxy to vote at the Annual General Meeting of Shareholders, or the "Annual Meeting", of Zura Bio Limited, including at any adjournments thereof, to be held on Wednesday, October 23, 2024 at 12:00 p.m. Eastern time and will be held in a virtual format. Please visit the website https://web.viewproxy.com/zura/2024 to register to attend the Annual Meeting. The physical location for the Annual Meeting will be at the offices of Cooley LLP, located at 55 Hudson Yards, New York, New York 10001, United States of America. You are strongly urged to attend the Extraordinary General Meeting virtually. You are invited to attend the Annual Meeting to vote on the proposals described in this Proxy Statement. However, you do not need to attend the Annual Meeting to vote your shares. Instead, you may simply follow the instructions below to submit your proxy. As used in this Proxy Statement, references to "we," "us," "our" and the "Company" refer to Zura Bio Limited and references to "Class A ordinary shares," "Shares" and "Class A ordinary share" refer to the Company's Class A ordinary shares, par value $0.0001 per share. Why did I receive a notice regarding the availability of proxy materials on the internet? Pursuant to rules adopted by the Securities and Exchange Commission (the "SEC"), we have elected to provide access to

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.